PMA device
Edwards Pericardial Aortic Bioprosthesis and INSPIRIS RESILIA Aortic Valve
Edwards Lifesciences, LLC · Heart-Valve, Non-Allograft Tissue (LWR, Class III) · First FDA decision Jun 29, 2017, newest Dec 29, 2022Aortic stenosisMitral regurgitationTricuspid regurgitation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
9
Naming "Edwards Pericardial"
MAUDE reports
69
Brand "Edwards Pericardial", since 2015
PubMed studies
1
Mentioning "Edwards Pericardial"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Edwards Pericardial Aortic Bioprosthesis and INSPIRIS RESILIA Aortic Valve
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
P150048-S060 · Decided Dec 29, 2022 · 328 days after receipt · Normal 180 Day Track No User Fee
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
P150048-S043 · Decided Apr 10, 2020 · 144 days after receipt · Normal 180 Day Track No User Fee
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
- Edwards Pericardial Mitral BioprosthesisPMA supplement
P150048-S026 · Decided Nov 5, 2018 · 59 days after receipt · Normal 180 Day Track No User Fee
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Edwards Pericardial", any status and sponsor, newest update first.
- ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve ReplacementPivotal-lookingActive, not recruiting
Boston Scientific CorporationPublic (BSX)
NCT03735667 · 1,948 participants · Start Jun 10, 2019 · Primary completion Jun 14, 2024
Device: ACURATE neo2™ Transfemoral TAVR System; Medtronic CoreValve TAVR System and 2 more · For: Aortic Stenosis
Sites: Birmingham, Alabama; Phoenix, Arizona; Scottsdale, Arizona · 75 sites in all
Edwards LifesciencesPublic (EW)
NCT01757665 · 777 participants · Start Dec 11, 2012 · Primary completion Aug 2017
Device: Edwards Aortic and Mitral Bioprostheses Models 11000A and 11000M · For: Aortic Stenosis; Mitral Stenosis; Aortic Valve Insufficiency and 2 more
Sites: Birmingham, Alabama; Los Angeles, California; Sacramento, California · 32 sites in all
Edwards LifesciencesPublic (EW)
NCT00853632 · 329 participants · Start Aug 2007 · Primary completion Mar 6, 2024
Device: CEP MAGNA MITRAL PERICARDIAL BIOPROSTHESES · For: Coronary Artery Disease; Mitral Valve Regurgitation; Mitral Valve Incompetence and 1 more
Sites: Sacramento, California; Orlando, Florida; Chicago, Illinois · 15 sites in all
6 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Edwards Pericardial", and for the whole product code for context.
This brand
69 reports: 29 malfunction, 40 injury, 0 death
Whole product code LWR
17,256 reports: 871 malfunction, 15,439 injury, 934 death
Newest reports for this brand
- Edwards Pericardial PatchMalfunction
2015691-2026-18881 · Received Sep 28, 2026 · Event dated Sep 3, 2026
Device type: Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene (DXZ)
Device problem as coded: Leak/Splash
Patient problem as coded: Blurred Vision; Burning Sensation; Chemical Exposure
- Edwards Pericardial PatchMalfunction
2015691-2026-18882 · Received Sep 28, 2026 · Event dated Aug 17, 2026
Device type: Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene (DXZ)
Device problem as coded: Leak/Splash
Patient problem as coded: Chemical Exposure
- Edwards Pericardial PatchMalfunction
2015691-2026-18883 · Received Sep 28, 2026 · Event dated Aug 28, 2026
Device type: Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene (DXZ)
Device problem as coded: Leak/Splash
Patient problem as coded: Chemical Exposure
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Edwards Pericardial"[tiab]. The summary above synthesizes these.
- Mitral Valve Replacement Using Carpentier-Edwards Pericardial Bioprosthesis in Patients With Rheumatic Heart Disease Aged Below 40 Years: 17-Year Results.
Chowdhury UK, Rizvi A, Narang R, et al. · Heart Lung Circ · 2018
Other devices of this type
Also filed under product code LWR.
- St. Jude Medical Biocor and Biocor Supra ValvesAbbott Medical · PMA 2012
- INSPIRIS RESILIA Aortic ValveEdwards Lifesciences, LLC · PMA 2026
- Mitroflow Aortic Pericardial Heart ValveCorcym Canada Corp · PMA 2019
- TRIFORMIS RESILIA Tricuspid ValveEdwards Lifesciences, LLC · PMA 2026
- Perceval Sutureless Heart Valve, Perceval Plus Sutureless Heart ValveCorcym S.r.l. · PMA 2025
- Sjm Biocor Valve / Sjm Biocor Supra ValveAbbott Medical · PMA 2016
- Ats 3F Aortic Bioprosthesis Model 1000Medtronic, Inc. · PMA 2019
- Freestyle Aortic Root BioprosthesisMedtronic, Inc. · PMA 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.